Annie Bakker

CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.

Heidi H. van Ojik, Lisette Bevaart, Christopher E. Dahle et al. · PubMed · 2003 · 93 citations

Lymphoid Neoplasia, Gene Therapies, Cancer Immunosurveillance +15

Mac-1 (CD11b/CD18) is crucial for effective Fc receptor–mediated immunity to melanoma

Annemiek B. van Spriel, Heidi H. van Ojik, Annie Bakker et al. · Blood · 2002 · 71 citations · Full text

Inside-Out Regulation of FcαRI (CD89) Depends on PP2A

Jantine E. Bakema, Annie Bakker, Simone de Haij et al. · The Journal of Immunology · 2008 · 28 citations · Full text

Reduction of EGP‐2‐positive pulmonary metastases by bispecific‐antibody‐redirected T cells in an immunocompetent rat model

B. J. Kroesen, Wijnand Helfrich, Annie Bakker et al. · International Journal of Cancer · 1995 · 18 citations

Cancer Immunosurveillance, Bsmab Bis-19, Rat Ril-2 +15

The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity

B. J. Kroesen, Wellenberg Gj, Annie Bakker et al. · British Journal of Cancer · 1996 · 11 citations · Full text

T-regulatory Cell, Apoptosis, Immunology +5